Treatment success rate: new TB cases in Eastern Mediterranean (WHO region)
Eastern Mediterranean (WHO region): Treatment success rate: new TB cases was 93 in 2023. ▲ Rising
Treatment success rate: new TB cases in Eastern Mediterranean (WHO region), 1995–2023
Source: World Health Organization, Global Health Observatory.
Analysis
Eastern Mediterranean (WHO region) recorded 93 for treatment success rate: new tb cases in 2023. That is the highest value across all 29 years on record.
Compared with earlier readings it is up 2.2% over ten years.
Over the whole period, treatment success rate: new tb cases in Eastern Mediterranean (WHO region) peaked at 93 in 2022 and was at its lowest, 57, in 1998.
The long-run direction has been consistently rising across the 29 years of available data.
Treatment success rate: new TB cases in Eastern Mediterranean (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 1995 | 79 | — |
| 1996 | 66 | -16.5% |
| 1997 | 73 | +10.6% |
| 1998 | 57 | -21.9% |
| 1999 | 79 | +38.6% |
| 2000 | 81 | +2.5% |
| 2001 | 82 | +1.2% |
| 2002 | 84 | +2.4% |
| 2003 | 82 | -2.4% |
| 2004 | 82 | +0.0% |
| 2005 | 82 | +0.0% |
| 2006 | 86 | +4.9% |
| 2007 | 87 | +1.2% |
| 2008 | 87 | +0.0% |
| 2009 | 87 | +0.0% |
| 2010 | 88 | +1.1% |
| 2011 | 89 | +1.1% |
| 2012 | 87 | -2.2% |
| 2013 | 91 | +4.6% |
| 2014 | 91 | +0.0% |
| 2015 | 91 | +0.0% |
| 2016 | 92 | +1.1% |
| 2017 | 91 | -1.1% |
| 2018 | 91 | +0.0% |
| 2019 | 91 | +0.0% |
| 2020 | 92 | +1.1% |
| 2021 | 92 | +0.0% |
| 2022 | 93 | +1.1% |
| 2023 | 93 | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 70.8 | 57 | 79 | 5 |
| 2000s | 84 | 81 | 87 | 10 |
| 2010s | 90.2 | 87 | 92 | 10 |
| 2020s | 92.5 | 92 | 93 | 4 |
Countries ranked near Eastern Mediterranean (WHO region)
- 1 Saint Kitts and Nevis 100 compare
- 1 Barbados 100 compare
- 1 Tonga 100 compare
- 1 Cook Islands 100 compare
- 1 Andorra 100 compare
- 1 Samoa 100 compare
- 1 Palestine, State of 100 compare
More health data for Eastern Mediterranean (WHO region)
- Measles - number of reported cases, gaps filled 83,590 (2025)
- Diphtheria - number of reported cases, gaps filled 5,830 (2025)
- Pertussis - number of reported cases, gaps filled 14,992 (2025)
- Total tetanus - number of reported cases, gaps filled 524 (2025)
- Measles - number of reported cases, annual growth rate 6.13 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 140.84 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 11.73 % change on previous year (2025)
- Diphtheria - number of reported cases 5,830 (2025)
- Pertussis - number of reported cases 14,992 (2025)
- Measles - number of reported cases 83,590 (2025)
Frequently asked questions
- What is treatment success rate: new tb cases in Eastern Mediterranean (WHO region)?
- Treatment success rate: new tb cases in Eastern Mediterranean (WHO region) was 93 in 2023, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate: new tb cases recorded in Eastern Mediterranean (WHO region)?
- The highest recorded value was 93 in 2022.
- What is the lowest treatment success rate: new tb cases recorded in Eastern Mediterranean (WHO region)?
- The lowest recorded value was 57 in 1998.
- How does Eastern Mediterranean (WHO region) rank for treatment success rate: new tb cases?
- Eastern Mediterranean (WHO region) ranks 1st out of 11 groups with data for 2023.
- Is treatment success rate: new tb cases rising or falling in Eastern Mediterranean (WHO region)?
- Over the last ten years it is up 2.2%. The long-run trend across the full record is rising.
- Where does this Eastern Mediterranean (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate: new TB cases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 29 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).